Bath & Body Works beats Q4 estimates despite a sales dip, while advancing its Consumer First Formula to support innovation and long-term growth.

Core EBITDA grew to 1,211 million USD, up 18.9% year-on-year at constant currency, ahead of net sales growth. Reported Core EBITDA margin was 23.3%, representing a year-on-year margin expansion of 24 ...

This edition includes coverage of a city council resolution on Flock cameras, an RDC vote on residential TIF, a forum for ...

Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year 2025. Record net ...